C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.
Monika Bitzer(Heinrich Heine University Düsseldorf), Mario Sarbia(Pathologie Hamburg-West), Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Helmut E. Gabbert(Heinrich Heine University Düsseldorf), Hansjörg Heep, Bodo Klump, Jawed Arjumand, Martin Rees
PubMed
July 25, 2003
Cited by 36
Related Papers
Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis
|Genes & Development|2009|351
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|202
Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L
|The EMBO Journal|2011|179
Hsp90 is regulated by a switch point in the C‐terminal domain
|EMBO Reports|2009|173
Decrease in plasma membrane tension triggers PtdIns(4,5)P2 phase separation to inactivate TORC2
|Nature Cell Biology|2018|151